V8 Peptides — Engineered Performance
Research Library
GHK-Cu vs AHK-Cu in Hair Follicle Research
GHK-CuComparison

GHK-Cu vs AHK-Cu in Hair Follicle Research

V8 Peptides Research TeamUpdated

Compiled from peer-reviewed literature and manufacturer analytical data for laboratory research reference.

Quick answer

What does hair follicle research on GHK-Cu actually show? The primary hair follicle experiment in this family, ex vivo human follicles and dermal papilla cells, used AHK-Cu, not GHK-Cu. GHK-Cu follicle statements in the cited literature are review-level summaries. A GHK-Cu follicle study needs staged follicles, copper-only and peptide-only arms, a log-spaced concentration range and blinded measurement. Calculate stocks with the reconstitution calculator.

Two copper tripeptides with near-identical names are often merged in hair follicle summaries. This guide separates the evidence by molecule, explains the follicle models used in the literature and sets out what a properly controlled GHK-Cu follicle experiment would need. The material is supplied for laboratory research use only; not for human consumption.

The attribution problem in hair follicle copper peptide research

Anyone reading about copper peptides and hair follicles meets a labeling problem quickly. Two related tripeptide-copper complexes are in the literature: GHK-Cu, glycyl-L-histidyl-L-lysine-Cu²⁺, and AHK-Cu, L-alanyl-L-histidyl-L-lysine-Cu²⁺. They differ by one amino acid, their names are similar, and summaries often merge them. The best-known controlled hair follicle experiment in this family used AHK-Cu, not GHK-Cu (Pyo and colleagues, 2007). A researcher who cites that paper as evidence for GHK-Cu is misattributing it.

This guide separates what was done with which molecule, explains the follicle models in which such experiments are run, and sets out the controls a GHK-Cu follicle study would need. The GHK-Cu product page describes the V8 material as Gly-His-Lys, copper-bound, in 50 mg and 100 mg lyophilized vials with ≥98% HPLC purity. All material discussed is supplied for laboratory research use only; not for human consumption.

Who did what: separating GHK-Cu and AHK-Cu evidence

SourceMoleculeSystemWhat was reported
Pyo and colleagues, 2007AHK-Cu (10⁻¹² to 10⁻⁹ M)Human hair follicles ex vivo; cultured dermal papilla cellsStimulated follicle elongation ex vivo and dermal papilla cell proliferation; at 10⁻⁹ M raised the Bcl-2/Bax ratio and reduced cleaved caspase-3 and PARP; the fall in apoptotic cell number was not statistically significant
Pickart, 2008 (review)GHK and GHK-CuSummary of earlier workLists increased hair follicle size among reported actions, alongside fibroblast and keratinocyte proliferation and angiogenesis
Pickart and colleagues, 2015 (review)GHK-CuSummary of earlier workLists wound healing of hair follicles among reported tissue-repair findings
Pickart and Margolina, 2018 (review)GHK-CuGene-expression and literature reviewLinks wide biological actions to regulation of many genes

The AHK-Cu study also reports that the tripeptide-copper complex, described as a growth factor for several kinds of differentiated cells, stimulates dermal fibroblast proliferation and VEGF production and decreases fibroblast TGF-β1 secretion (Pyo and colleagues, 2007). That is a statement about the family of complexes in the paper's introduction, not new GHK-Cu data. The reviews are secondary sources and give no primary measurements of their own. Taken together, the table shows that primary follicle data in the cited literature are for AHK-Cu, and the GHK-Cu follicle statements are review-level summaries.

Hair follicle biology that shapes every experiment

The hair follicle is a miniature organ that cycles between growth, regression and rest, and its behavior reflects interactions among epithelial and mesenchymal compartments (Paus and Cotsarelis, 1999; Schneider and colleagues, 2009). The dermal papilla, a cluster of specialized fibroblasts at the base of the follicle, is central to follicle morphogenesis and growth, which is why dermal papilla cells are used as an in vitro surrogate. Because follicle behavior depends on cycle stage, a model that does not control for stage produces noisy data.

Model systems for follicle research

ModelWhat it preservesWhat it lacksTypical readouts
Cultured dermal papilla cellsMesenchymal inductive cell typeEpithelium, matrix and follicle architectureProliferation, apoptosis markers, growth-factor secretion
Human hair follicle organ culture (ex vivo)Intact follicle, both compartmentsVascular and neural input, hormonal milieu, limited lifespanShaft elongation measured by videomicroscope, cycle markers
Mouse skin in vivoWhole skin and synchronized cycle in defined strainsSpecies differences from human folliclesHair regrowth, histology of cycle stage
Co-culture of papilla cells with keratinocytesSome epithelial–mesenchymal signalingIncomplete architectureReporter or marker expression

Ex vivo human follicle culture illustrates the design problems clearly. A methods study of occipital scalp follicles found considerable variation in hair growth and follicle length among follicles, but the two variables correlated well; hair growth in culture was closely related to the growth rate in vivo, and a reference agent, minoxidil, showed a significant increase in hair growth only in follicles categorized as being at a similar early anagen VI stage (Kwon and colleagues, 2005). The lesson is that selecting follicles by a defined stage and pre-culture growth rate reduces variability and decides whether a real effect can be seen at all.

What a GHK-Cu follicle experiment needs

  • Exact molecule. State GHK-Cu, not "copper peptide", and cite only GHK-Cu primary data for GHK-Cu claims.
  • Staged follicles. Select anagen VI follicles by measured growth before assigning them to groups, as in the categorization study above.
  • Within-donor allocation. Spread follicles from each donor across all groups so that donor differences do not become exposure effects.
  • Concentration range. The AHK-Cu study used 10⁻¹² to 10⁻⁹ M; matrix studies with GHK-Cu showed biphasic curves (Wegrowski and colleagues, 1992), so test a log-spaced range of at least five points. Stock arithmetic is mass divided by volume; the reconstitution calculator carries it out.
  • Component controls. GHK-Cu, copper salt and peptide without copper at matched molar concentrations.
  • Positive control. A reference agent known to lengthen cultured follicles in the chosen protocol, as minoxidil did in the staged-follicle study.
  • Blinded measurement. Follicle length from videomicroscope images measured blind to group.
  • Viability and apoptosis readouts. Report them next to proliferation, because the AHK-Cu paper itself found a non-significant change in apoptotic cell number.
  • Medium record. Serum, albumin and histidine bind copper (Lau and Sarkar, 1981), so write down the exact medium.

Reading the apoptosis result honestly

The AHK-Cu paper is a good example of careful reporting that is easy to over-read. The 10⁻⁹ M concentration reduced the number of apoptotic dermal papilla cells, but the authors state that the decrease was not statistically significant. Supporting measurements pointed in the same direction: the Bcl-2/Bax ratio was elevated and cleaved caspase-3 and PARP were reduced. The paper proposed that the complex promotes follicle growth through stimulation of proliferation and preclusion of apoptosis of dermal papilla cells (Pyo and colleagues, 2007). The word "proposed" matters. A secondary source that says the complex "prevents apoptosis" has dropped the qualifier, and an experiment built on that statement inherits the error.

Where GHK-Cu evidence would have to come from

To claim an effect of GHK-Cu on follicle growth in a model, an experiment would have to use GHK-Cu and measure the follicle readout directly. The elements exist: follicle organ culture, papilla cell cultures, defined concentrations, a copper-handling protocol. What the cited literature supplies for GHK-Cu itself is gene-expression, matrix and fibroblast data and review-level statements. The library covers related background in the GHK-Cu research overview and in GHK-Cu copper peptide research, and related copper peptide contrasts in GHK-Cu vs other copper peptides.

A reporting checklist for follicle papers

Item to reportWhy it matters
Exact molecule and lot, with identity data where publishedGHK-Cu and AHK-Cu differ by one residue; lot identity prevents mix-ups
Donor number, sex, age and scalp siteFollicle behavior varies between donors and body sites
Follicle selection criteria and cycle stageUnstaged follicles add noise that can hide or fake an effect
Culture medium, serum and supplementsAlbumin and histidine in medium bind copper
Culture duration and medium-change scheduleEx vivo follicles have a limited lifespan, so length of observation sets what can be seen
Measurement method and blindingVideomicroscope length measurement can be biased if unblinded
Number of follicles per group and per donorThe unit of analysis should be the donor, not the individual follicle
Statistics, including non-significant resultsThe AHK-Cu paper reported a non-significant apoptosis change; omitting such results inflates conclusions

Reagent identity as part of the answer

Because the two tripeptides differ by one residue, identity verification has real value. HPLC retention and mass will distinguish GHK from AHK, and a certificate that states an identity method protects against confusing them. See GHK-Cu purity testing, understanding HPLC purity and the COA library. Store the powder at 2–8 °C, −20 °C for long-term, away from heat, moisture and light, as the product page states, and avoid reducing agents and chelators in stock solutions, as set out in does copper degrade other peptides in a blend.

All material discussed is supplied for laboratory research use only; not for human consumption.

Related reading

Frequently asked questions

Is the well-known hair follicle copper peptide study about GHK-Cu?

No. The ex vivo human follicle and dermal papilla cell study used AHK-Cu, L-alanyl-L-histidyl-L-lysine-Cu²⁺, which differs from GHK-Cu by one amino acid.

What concentrations did the AHK-Cu follicle study use?

10⁻¹² to 10⁻⁹ M. It reported stimulated follicle elongation ex vivo and dermal papilla cell proliferation across that range.

Did AHK-Cu significantly reduce apoptosis?

The decrease in apoptotic dermal papilla cells at 10⁻⁹ M was not statistically significant, although Bcl-2/Bax rose and cleaved caspase-3 and PARP fell.

What do the GHK-Cu reviews say about hair follicles?

Reviews list increased hair follicle size and wound healing of follicles among reported actions. They are secondary sources and contain no new follicle measurements.

Why use dermal papilla cells?

They are specialized fibroblasts important in follicle morphogenesis and growth, so they serve as a simple in vitro surrogate, though they lack epithelium and architecture.

Why stage hair follicles before an ex vivo experiment?

Follicles vary in growth and length. Selecting follicles at a defined early anagen VI stage by growth rate gave more reliable outcomes in a methods study.

What positive control was used in that methods study?

Minoxidil, which showed a significant increase in hair growth only in follicles categorized at a similar early anagen VI stage.

What controls are needed for a GHK-Cu follicle study?

Exact molecule, staged follicles, within-donor allocation, a concentration range, copper-only and peptide-only arms, a positive control and blinded measurement.

How can GHK and AHK be told apart analytically?

By HPLC retention and mass spectrometry, since the molecular masses differ. A certificate that states an identity method helps.

Do these studies show effects in humans?

No. The primary data are ex vivo and in vitro, and this library makes no human-use claims.

Related reading: GHK-Cu Long-Term Tissue Research: Time-Course Design, GHK-Cu Mechanisms: Copper Binding and Signaling, GHK-Cu Gene Expression and Wound Repair: A Literature Guide.

References

  1. Pyo HK, Yoo HG, Won CH, et al. The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res. 2007;30(7):834-839. doi:10.1007/BF02978833
  2. Kwon OS, Oh JK, Kim MH, et al. Human hair growth ex vivo is correlated with in vivo hair growth: selective categorization of hair follicles for more reliable hair follicle organ culture. Arch Dermatol Res. 2005;297(8):367-371. doi:10.1007/s00403-005-0619-z
  3. Paus R, Cotsarelis G. The biology of hair follicles. N Engl J Med. 1999;341(7):491-497. doi:10.1056/NEJM199908123410706
  4. Schneider MR, Schmidt-Ullrich R, Paus R. The hair follicle as a dynamic miniorgan. Curr Biol. 2009;19(3):R132-R142. doi:10.1016/j.cub.2008.12.005
  5. Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-988. doi:10.1163/156856208784909435
  6. Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015;2015:648108. doi:10.1155/2015/648108
  7. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987. doi:10.3390/ijms19071987
  8. Wegrowski Y, Maquart FX, Borel JP. Stimulation of sulfated glycosaminoglycan synthesis by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. Life Sci. 1992;51(13):1049-1056. doi:10.1016/0024-3205(92)90504-I
  9. Lau SJ, Sarkar B. The interaction of copper(II) and glycyl-L-histidyl-L-lysine, a growth-modulating tripeptide from plasma. Biochem J. 1981;199(3):649-656. doi:10.1042/bj1990649

Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.